Investing.com - Zimmer Biomet reported on Friday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Zimmer Biomet announced earnings per share of $1.81 on revenue of $1.93B. Analysts polled by Investing.com anticipated EPS of $1.07 on revenue of $1.71B.
Zimmer Biomet shares are down 6% from the beginning of the year, still down 13.51% from its 52 week high of $161.11 set on February 19. They are under-performing the S&P 500 which is up 8.66% from the start of the year.
Zimmer Biomet follows other major Healthcare sector earnings this month
Zimmer Biomet's report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Thermo Fisher Scientific had beat expectations on October 21 with third quarter EPS of $5.63 on revenue of $8.52B, compared to forecast for EPS of $4.33 on revenue of $7.65B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar